{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:55Z","timestamp":1792783495824,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Milano","id":[{"id":"https:\/\/ror.org\/00wjc7c48","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Myasthenia gravis (MG) is a chronic autoimmune disorder that involves the targeting of neuromuscular junctions and is primarily driven by autoantibodies against the acetylcholine receptor (AChR). While genetic susceptibility is a factor, environmental triggers, particularly viral infections, are being increasingly investigated as potential contributors to MG pathogenesis. This review examines the complex interplay between viral pathogens and MG, highlighting mechanisms such as molecular mimicry, bystander activation, and the aberrant stimulation of innate immune pathways via Toll-like receptors (TLRs). Key DNA viruses, including Epstein\u2012Barr virus (EBV) and parvovirus B19, have been detected within hyperplastic thymic tissues and thymomas, suggesting that they may sustain local autoreactive B-cell activation. Furthermore, recent clinical data emphasize the role of RNA viruses, most notably SARS-CoV-2, as significant triggers of new-onset MG and myasthenic crises. Despite substantial evidence linking viral infections to MG, further mechanistic research and large-scale observational studies are needed to definitively establish causality and refine therapeutic strategies targeting these virus-induced immune responses.<\/jats:p>","DOI":"10.1007\/s13365-026-01334-6","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:09:37Z","timestamp":1787753377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Possible involvement of viral infection in the pathogenesis of myasthenia gravis"],"prefix":"10.1007","volume":"32","author":[{"given":"Maria","family":"Dolci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Signorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Perego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Passerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Giannasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Camurri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Berni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Pietropaolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Baj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3199-9369","authenticated-orcid":false,"given":"Serena","family":"Delbue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"1334_CR1","first-page":"8845844","volume":"2020","author":"E Aksoy","year":"2020","unstructured":"Aksoy E, Oztutgan T (2020) COVID-19 Presentation in Association with Myasthenia Gravis: A Case Report and Review of the Literature. Case Rep Infect Dis 2020:8845844","journal-title":"Case Rep Infect Dis"},{"key":"1334_CR2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1586\/1744666X.2015.1047345","volume":"11","author":"M Alahgholi-Hajibehzad","year":"2015","unstructured":"Alahgholi-Hajibehzad M, Kasapoglu P, Jafari R, Rezaei N (2015) The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics. Expert Rev Clin Immunol 11:859\u2013870","journal-title":"Expert Rev Clin Immunol"},{"key":"1334_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/0049475516655069","volume":"47","author":"FA Altay","year":"2017","unstructured":"Altay FA, G\u00fcven H, \u015eent\u00fcrk G, Ferik S, \u015eencan \u0130, \u00c7omo\u011flu S (2017) Is West Nile Virus infection associated with myasthenia gravis? Trop Doct 47:30\u201334","journal-title":"Trop Doct"},{"key":"1334_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3201\/eid2005.131551","volume":"20","author":"A Belbezier","year":"2014","unstructured":"Belbezier A, Deroux A, Sarrot-Reynauld F, Larrat S, Bouillet L (2014) Myasthenia gravis associated with acute hepatitis E infection in immunocompetent woman. Emerg Infect Dis 20:908\u2013910","journal-title":"Emerg Infect Dis"},{"key":"1334_CR5","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1007\/s10072-023-07002-5","volume":"44","author":"L Carmillo","year":"2023","unstructured":"Carmillo L, Congedo P, Caggiula M, Nuzzo MM, Fasano A (2023) MuSK myasthenia gravis as a manifestation of immune reconstitution inflammatory syndrome in an HIV-positive patient: a challenging diagnosis and therapeutic approach. Neurol Sci 44:4575\u20134577","journal-title":"Neurol Sci"},{"key":"1334_CR6","first-page":"e67511","volume":"16","author":"B Castro Silva","year":"2024","unstructured":"Castro Silva B, Saianda Duarte M, Rodrigues Alves N, Vicente P, Ara\u00fajo J (2024) Seronegative Myasthenia Gravis: A Rare Disease Triggered by SARS-CoV-2 or a Coincidence? Cureus 16:e67511","journal-title":"Cureus"},{"key":"1334_CR7","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1212\/WNL.0b013e3181d7d884","volume":"74","author":"P Cavalcante","year":"2010","unstructured":"Cavalcante P, Barberis M, Cannone M, Baggi F, Antozzi C, Maggi L, Cornelio F, Barbi M, Did\u00f2 P, Berrih-Aknin S, Mantegazza R, Bernasconi P (2010a) Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis. Neurology 74:1118\u20131126","journal-title":"Neurology"},{"key":"1334_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/nyas.13534","volume":"1413","author":"P Cavalcante","year":"2018","unstructured":"Cavalcante P, Barzago C, Baggi F, Antozzi C, Maggi L, Mantegazza R, Bernasconi P (2018) Toll-like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity? Ann N Y Acad Sci 1413:11\u201324","journal-title":"Ann N Y Acad Sci"},{"key":"1334_CR9","doi-asserted-by":"crossref","unstructured":"Cavalcante P, Cufi P, Mantegazza R, Berrih-Aknin S, Bernasconi P and R. Le Panse (2013) Etiology of myasthenia gravis: innate immunity signature in pathological thymus. Autoimmun Rev 12:863\u2013874","DOI":"10.1016\/j.autrev.2013.03.010"},{"key":"1334_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.imbio.2015.12.007","volume":"221","author":"P Cavalcante","year":"2016","unstructured":"Cavalcante P, Galbardi B, Franzi S, Marcuzzo S, Barzago C, Bonanno S, Camera G, Maggi L, Kapetis D, Andreetta F, Biasiucci A, Motta T, Giardina C, Antozzi C, Baggi F, Mantegazza R, Bernasconi P (2016) Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection. Immunobiology 221:516\u2013527","journal-title":"Immunobiology"},{"key":"1334_CR11","first-page":"213092","volume":"2011","author":"P Cavalcante","year":"2011","unstructured":"Cavalcante P, Maggi L, Colleoni L, Caldara R, Motta T, Giardina C, Antozzi C, Berrih-Aknin S, Bernasconi P, Mantegazza R (2011) Inflammation and epstein-barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis. Autoimmune Dis 2011:213092","journal-title":"Autoimmune Dis"},{"key":"1334_CR12","doi-asserted-by":"publisher","first-page":"1404191","DOI":"10.3389\/fimmu.2024.1404191","volume":"15","author":"P Cavalcante","year":"2024","unstructured":"Cavalcante P, Mantegazza R, Antozzi C (2024) Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis. Front Immunol 15:1404191","journal-title":"Front Immunol"},{"key":"1334_CR13","doi-asserted-by":"publisher","first-page":"95432","DOI":"10.18632\/oncotarget.20731","volume":"8","author":"P Cavalcante","year":"2017","unstructured":"Cavalcante P, Marcuzzo S, Franzi S, Galbardi B, Maggi L, Motta T, Ghislandi R, Buzzi A, Spinelli L, Novellino L, Baggi F, Antozzi C, Conforti F, De Pas TM, Barberis M, Bernasconi P, Mantegazza R (2017) Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator? Oncotarget 8:95432\u201395449","journal-title":"Oncotarget"},{"key":"1334_CR14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.21902","volume":"67","author":"P Cavalcante","year":"2010","unstructured":"Cavalcante P, Serafini B, Rosicarelli B, Maggi L, Barberis M, Antozzi C, Berrih-Aknin S, Bernasconi P, Aloisi F, Mantegazza R (2010b) Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus. Ann Neurol 67:726\u2013738","journal-title":"Ann Neurol"},{"key":"1334_CR15","first-page":"e33048","volume":"14","author":"T Chatterjee","year":"2022","unstructured":"Chatterjee T, Senthil Kumaran S, Roy M (2022) A Case Report and Literature Review of New-Onset Myasthenia Gravis After COVID-19 Infection. Cureus 14:e33048","journal-title":"Cureus"},{"key":"1334_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molimm.2021.02.011","volume":"133","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhang XS, Wang YG, Lu C, Li J, Zhang P (2021) Imbalance of Th17 and Tregs in thymoma may be a pathological mechanism of myasthenia gravis. Mol Immunol 133:67\u201376","journal-title":"Mol Immunol"},{"key":"1334_CR16","doi-asserted-by":"crossref","unstructured":"Chen YH, Wu KH, Wu HP (2024) Unraveling the complexities of toll-like receptors: from molecular mechanisms to clinical applications. Int J Mol Sci 25","DOI":"10.3390\/ijms25095037"},{"key":"1334_CR18","doi-asserted-by":"crossref","unstructured":"Chteinberg E, Klufah F, Rennspiess D, Mannheims MF, Abdul-Hamid MA, Losen M, Keijzers M, De Baets MH, Kurz AK and A. Zur Hausen (2019) Low prevalence of Merkel cell polyomavirus in human epithelial thymic tumors. Thorac Cancer 10:445\u2013451","DOI":"10.1111\/1759-7714.12953"},{"key":"1334_CR19","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1468-1331.2011.03636.x","volume":"19","author":"D Csuka","year":"2012","unstructured":"Csuka D, Banati M, Rozsa C, F\u00fcst G, Illes Z (2012) High anti-EBNA-1 IgG levels are associated with early-onset myasthenia gravis. Eur J Neurol 19:842\u2013846","journal-title":"Eur J Neurol"},{"key":"1334_CR20","doi-asserted-by":"publisher","first-page":"116888","DOI":"10.1016\/j.jns.2020.116888","volume":"414","author":"F Delly","year":"2020","unstructured":"Delly F, Syed MJ, Lisak RP, Zutshi D (2020) Myasthenic crisis in COVID-19. J Neurol Sci 414:116888","journal-title":"J Neurol Sci"},{"key":"1334_CR22","doi-asserted-by":"publisher","first-page":"1513599","DOI":"10.3389\/fimmu.2025.1513599","volume":"16","author":"X Deng","year":"2025","unstructured":"Deng X, Gong X, Zhou D (2025) Perturbations in gut microbiota composition in patients with autoimmune neurological diseases: a systematic review and meta-analysis. Front Immunol 16:1513599","journal-title":"Front Immunol"},{"key":"1334_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","volume":"78","author":"J D\u00edaz-Manera","year":"2012","unstructured":"D\u00edaz-Manera J, Mart\u00ednez-Hern\u00e1ndez E, Querol L, Klooster R, Rojas-Garc\u00eda R, Su\u00e1rez-Calvet X, Mu\u00f1oz-Blanco JL, Mazia C, Straasheijm KR, Gallardo E, Ju\u00e1rez C, Verschuuren JJ, Illa I (2012) Long-lasting treatment effect of rituximab in MuSK myasthenia. Neurology 78:189\u2013193","journal-title":"Neurology"},{"key":"1334_CR23","first-page":"67","volume":"182","author":"N Dragin","year":"2025","unstructured":"Dragin N, Le Panse R (2025) Thymic physiology and pathophysiology in Myasthenia Gravis. Int Rev Neurobiol 182:67\u201388","journal-title":"Int Rev Neurobiol"},{"key":"1334_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/08830738050200051501","volume":"20","author":"KJ Felice","year":"2005","unstructured":"Felice KJ, DiMario FJ, Conway SR (2005) Postinfectious myasthenia gravis: report of two children. J Child Neurol 20:441\u2013444","journal-title":"J Child Neurol"},{"key":"1334_CR26","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.3389\/fimmu.2019.03052","volume":"10","author":"KL Gable","year":"2019","unstructured":"Gable KL, Guptill JT (2019) Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis. Front Immunol 10:3052","journal-title":"Front Immunol"},{"key":"1334_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/bs.irn.2025.04.028","volume":"182","author":"NE Gilhus","year":"2025","unstructured":"Gilhus NE, Breiner A (2025) Epidemiology of myasthenia gravis. Int Rev Neurobiol 182:161\u2013196","journal-title":"Int Rev Neurobiol"},{"key":"1334_CR28","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00415-018-8751-9","volume":"265","author":"NE Gilhus","year":"2018","unstructured":"Gilhus NE, Romi F, Hong Y, Skeie GO (2018) Myasthenia gravis and infectious disease. J Neurol 265:1251\u20131258","journal-title":"J Neurol"},{"key":"1334_CR29","doi-asserted-by":"publisher","first-page":"109e7","DOI":"10.1016\/j.cmi.2018.03.036","volume":"25","author":"L Gong","year":"2019","unstructured":"Gong L, Li Y, Li X, Tu Q, Mou X, Wang S, Wan Y, Lu Q, Wang J, Zhang W, Zhu S, Han X, Yao L, Zhang J, Huang G (2019) Detection of human parvovirus B19 infection in the thymus of patients with thymic hyperplasia-associated myasthenia gravis. Clin Microbiol Infect 25:109e7\u201309e12","journal-title":"Clin Microbiol Infect"},{"key":"1334_CR30","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1245\/s10434-022-12936-9","volume":"30","author":"L Gong","year":"2023","unstructured":"Gong L, Tian J, Zhang Y, Feng Z, Wang Q, Wang Y, Zhang F, Zhang W, Huang G (2023) Human Parvovirus B19 May Be a Risk Factor in Myasthenia Gravis with Thymoma. Ann Surg Oncol 30:1646\u20131655","journal-title":"Ann Surg Oncol"},{"key":"1334_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","volume":"52","author":"A Gradolatto","year":"2014","unstructured":"Gradolatto A, Nazzal D, Truffault F, Bismuth J, Fadel E, Foti M, Berrih-Aknin S (2014) Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-\u03b1. J Autoimmun 52:53\u201363","journal-title":"J Autoimmun"},{"key":"1334_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.14740\/jocmr2413w","volume":"8","author":"M Greco","year":"2016","unstructured":"Greco M, Cofano P, Lobreglio G (2016) Seropositivity for West Nile Virus Antibodies in Patients Affected by Myasthenia Gravis. J Clin Med Res 8:196\u2013201","journal-title":"J Clin Med Res"},{"key":"1334_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1365-2893.1996.tb00106.x","volume":"3","author":"P Halfon","year":"1996","unstructured":"Halfon P, Levy M, San Marco M, Gerolami V, Khiri H, Bourliere M, Feryn JM, Gastaut JL, Pouget J, Cartouzou G (1996) Myasthenia gravis and hepatitis C virus infection. J Viral Hepat 3:329\u2013332","journal-title":"J Viral Hepat"},{"key":"1334_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2018.09.015","volume":"395","author":"MA Hawkes","year":"2018","unstructured":"Hawkes MA, Hocker SE, Leis AA (2018) West Nile virus induces a post-infectious pro-inflammatory state that explains transformation of stable ocular myasthenia gravis to myasthenic crises. J Neurol Sci 395:1\u20133","journal-title":"J Neurol Sci"},{"key":"1334_CR35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/15513815.2025.2486838","volume":"44","author":"L He","year":"2025","unstructured":"He L, Xu Y, Miao D, Zhang X (2025) Thymic Lymphoepithelial Carcinoma in Children: Report of Four Cases and Review of Literature. Fetal Pediatr Pathol 44:196\u2013205","journal-title":"Fetal Pediatr Pathol"},{"key":"1334_CR36","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3389\/fneur.2020.00775","volume":"11","author":"JM Heckmann","year":"2020","unstructured":"Heckmann JM, Marais S (2020) Management Issues in Myasthenia Gravis Patients Living With HIV: A Case Series and Literature Review. Front Neurol 11:775","journal-title":"Front Neurol"},{"key":"1334_CR37","doi-asserted-by":"crossref","unstructured":"Hill ME, Shiono H, Newsom-Davis J, Willcox N (2008) The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics. J Neuroimmunol 201\u2013202:50\u20136","DOI":"10.1016\/j.jneuroim.2008.06.027"},{"key":"1334_CR38","doi-asserted-by":"publisher","first-page":"576153","DOI":"10.3389\/fneur.2020.576153","volume":"11","author":"M Huber","year":"2020","unstructured":"Huber M, Rogozinski S, Puppe W, Framme C, H\u00f6glinger G, Hufendiek K, Wegner F (2020) Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient. Front Neurol 11:576153","journal-title":"Front Neurol"},{"key":"1334_CR39","first-page":"345","volume":"128","author":"F Jing","year":"2013","unstructured":"Jing F, Wei D, Wang D, Li N, Cui F, Yang F, Chen Z, Huang X (2013) Lack of Epstein-Barr virus infection in Chinese myasthenia gravis patients. Acta Neurol Scand 128:345\u2013350","journal-title":"Acta Neurol Scand"},{"key":"1334_CR41","doi-asserted-by":"crossref","unstructured":"J\u00f5gi K, Liis S, Merit R Leheste Alo-Rainer, and Vilisaar Janek (2022) New Onset Generalized Myasthenia Gravis Evolving Following SARS-CoV-2 Infection. COVID 2:464\u201371","DOI":"10.3390\/covid2040033"},{"key":"1334_CR40","doi-asserted-by":"publisher","first-page":"102962","DOI":"10.1016\/j.jaut.2022.102962","volume":"137","author":"D Johnson","year":"2023","unstructured":"Johnson D, Jiang W (2023) Infectious diseases, autoantibodies, and autoimmunity. J Autoimmun 137:102962","journal-title":"J Autoimmun"},{"key":"1334_CR42","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/ana.22488","volume":"70","author":"K Kakalacheva","year":"2011","unstructured":"Kakalacheva K, Maurer MA, Tackenberg B, M\u00fcnz C, Willcox N, L\u00fcnemann JD (2011) Intrathymic Epstein-Barr virus infection is not a prominent feature of myasthenia gravis. Ann Neurol 70:508\u2013514","journal-title":"Ann Neurol"},{"key":"1334_CR43","doi-asserted-by":"crossref","unstructured":"Kaminski HJ, Sikorski P, Coronel SI, Kusner LL (2024) Myasthenia gravis: the future is here. J Clin Invest 134","DOI":"10.1172\/JCI179742"},{"key":"1334_CR44","doi-asserted-by":"publisher","first-page":"106834","DOI":"10.1016\/j.clineuro.2021.106834","volume":"208","author":"N Karimi","year":"2021","unstructured":"Karimi N, Okhovat AA, Ziaadini B, Haghi Ashtiani B, Nafissi S, Fatehi F (2021) Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases. Clin Neurol Neurosurg 208:106834","journal-title":"Clin Neurol Neurosurg"},{"key":"1334_CR45","doi-asserted-by":"crossref","unstructured":"Khani-Habibabadi F, Roy B, Pham MC, Obaid AH, Filipek B, Nowak RJ and K. C. O\u2019Connor (2025) AChR Autoantibody Pathogenic Properties Are Heterogeneously Distributed and Undergo Temporal Changes Among Patients With Myasthenia Gravis. Neurol Neuroimmunol Neuroinflamm 12:e200436","DOI":"10.1212\/NXI.0000000000200436"},{"key":"1334_CR46","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1212\/WNL.35.9.1381","volume":"35","author":"LS Klavinskis","year":"1985","unstructured":"Klavinskis LS, Willcox N, Oxford JS, Newsom-Davis J (1985) Neurology 35:1381\u20131384 \u2018Antivirus antibodies in myasthenia gravis\u2019","journal-title":"Neurology"},{"key":"1334_CR47","first-page":"435","volume":"20","author":"IL Korn","year":"1981","unstructured":"Korn IL, Abramsky O (1981) Myasthenia gravis following viral infection. Eur Neurol 20:435\u20139U","journal-title":"Eur Neurol"},{"key":"1334_CR48","doi-asserted-by":"crossref","unstructured":"Ks A, Kumar V, Ms AR, Bhat NK (2023) Acute liver failure due to hepatitis A virus presented with Guillain-Barr\u00e9 syndrome and ocular myasthenia gravis. BMJ Case Rep 16","DOI":"10.1136\/bcr-2023-254855"},{"key":"1334_CR49","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/mus.20694","volume":"35","author":"PH Lalive","year":"2007","unstructured":"Lalive PH, Allali G, Truffert A (2007) Myasthenia gravis associated with HTLV-I infection and atypical brain lesions. Muscle Nerve 35:525\u2013528","journal-title":"Muscle Nerve"},{"key":"1334_CR50","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s13365-021-00950-8","volume":"27","author":"YH Lau","year":"2021","unstructured":"Lau YH, Chinnasami S (2021) Emergence of myasthenia gravis in dengue infection-first case report. J Neurovirol 27:183\u2013185","journal-title":"J Neurovirol"},{"key":"1334_CR51","doi-asserted-by":"publisher","first-page":"596981","DOI":"10.3389\/fneur.2020.596981","volume":"11","author":"K Lazaridis","year":"2020","unstructured":"Lazaridis K, Tzartos SJ (2020) Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management. Front Neurol 11:596981","journal-title":"Front Neurol"},{"key":"1334_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/mus.23869","volume":"49","author":"AA Leis","year":"2014","unstructured":"Leis AA, Szatmary G, Ross MA, Stokic DS (2014) West nile virus infection and myasthenia gravis. Muscle Nerve 49:26\u201329","journal-title":"Muscle Nerve"},{"key":"1334_CR53","doi-asserted-by":"crossref","unstructured":"Leopardi V, Chang YM, Pham A, Luo J and O. A. Garden (2021) A Systematic Review of the Potential Implication of Infectious Agents in Myasthenia Gravis. Front Neurol 12:618021","DOI":"10.3389\/fneur.2021.618021"},{"key":"1334_CR54","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nm0502-509","volume":"8","author":"MC Levin","year":"2002","unstructured":"Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FC, Hasty KA, Callaway JC, Zunt J, Desiderio D, Stuart JM (2002) Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 8:509\u2013513","journal-title":"Nat Med"},{"key":"1334_CR55","doi-asserted-by":"publisher","first-page":"777606","DOI":"10.3389\/fimmu.2021.777606","volume":"12","author":"H Li","year":"2021","unstructured":"Li H, Liu S, Han J, Li S, Gao X, Wang M, Zhu J, Jin T (2021) Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems. Front Immunol 12:777606","journal-title":"Front Immunol"},{"key":"1334_CR56","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jinf.2018.03.014","volume":"77","author":"HM Li","year":"2018","unstructured":"Li HM, Huang YK, Su YC, Kao CH (2018) Increased risk of autoimmune diseases in dengue patients: A population-based cohort study. J Infect 77:212\u2013219","journal-title":"J Infect"},{"key":"1334_CR57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.expneurol.2015.03.010","volume":"270","author":"M Losen","year":"2015","unstructured":"Losen M, Martinez-Martinez P, Molenaar PC, Lazaridis K, Tzartos S, Brenner T, Duan RS, Luo J, Lindstrom J, Kusner L (2015) Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors\u2013Recommendations for methods and experimental designs. Exp Neurol 270:18\u201328","journal-title":"Exp Neurol"},{"key":"1334_CR58","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3389\/fneur.2020.00981","volume":"11","author":"R Mantegazza","year":"2020","unstructured":"Mantegazza R, Antozzi C (2020) From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research. Front Neurol 11:981","journal-title":"Front Neurol"},{"key":"1334_CR59","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/BOR.0000000000000647","volume":"31","author":"R Mantegazza","year":"2019","unstructured":"Mantegazza R, Cavalcante P (2019) Diagnosis and treatment of myasthenia gravis. Curr Opin Rheumatol 31:623\u2013633","journal-title":"Curr Opin Rheumatol"},{"key":"1334_CR60","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2147\/ITT.S261414","volume":"9","author":"R Mantegazza","year":"2020","unstructured":"Mantegazza R, Vanoli F, Frangiamore R, Cavalcante P (2020) Complement Inhibition for the Treatment of Myasthenia Gravis. Immunotargets Ther 9:317\u2013331","journal-title":"Immunotargets Ther"},{"key":"1334_CR99","first-page":"385","volume":"131","author":"LJ McGuire","year":"1988","unstructured":"McGuire LJ, Huang DP, Teoh R, Arnold M, Wong K, Lee JC (1988) Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. Am J Pathol 131:385\u2013390. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1880705\/","journal-title":"Am J Pathol"},{"key":"1334_CR61","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/ana.22522","volume":"70","author":"M Meyer","year":"2011","unstructured":"Meyer M, H\u00f6ls AK, Liersch B, Leistner R, Gellert K, Schalke B, Marx A, Niedobitek G (2011) Lack of evidence for Epstein-Barr virus infection in myasthenia gravis thymus. Ann Neurol 70:515\u2013518","journal-title":"Ann Neurol"},{"key":"1334_CR62","doi-asserted-by":"crossref","unstructured":"Minc\u0103 A, Minc\u0103 DI, Calinoiu AL, Gheorghi\u021b\u0103 V, Popescu CC, Rusu A, Cristea AM and D. G. Minc\u0103 (2024) Myasthenia Gravis Triggered by a COVID-19 Infection: A Case Report and Literature Review. Cureus 16:e59538","DOI":"10.7759\/cureus.59538"},{"key":"1334_CR63","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1212\/WNL.0000000000003697","volume":"88","author":"N Molko","year":"2017","unstructured":"Molko N, Simon O, Guyon D, Biron A, Dupont-Rouzeyrol M, Gourinat AC (2017) Zika virus infection and myasthenia gravis: report of 2 cases. Neurology 88:1097\u20131098","journal-title":"Neurology"},{"key":"1334_CR64","doi-asserted-by":"crossref","unstructured":"Morawiec N, Adamczyk B, Spyra A, Herba M, Boczek S, Korbel N, Polecho\u0144ski P, Adamczyk-Sowa M (2025) The role of Epstein-Barr virus in the pathogenesis of autoimmune diseases. Med (Kaunas) 61","DOI":"10.3390\/medicina61071148"},{"key":"1334_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jns.2005.08.013","volume":"240","author":"M Mori","year":"2006","unstructured":"Mori M, Kuwabara S, Nemoto Y, Tamura N, Hattori T (2006) Concomitant chronic inflammatory demyelinating polyneuropathy and myasthenia gravis following cytomegalovirus infection. J Neurol Sci 240:103\u2013106","journal-title":"J Neurol Sci"},{"key":"1334_CR66","first-page":"524","volume":"4","author":"P Moschella","year":"2020","unstructured":"Moschella P, Roth P (2020) Isolated COVID-19 Infection Precipitates Myasthenia Gravis Crisis: A Case Report. Clin Pract Cases Emerg Med 4:524\u2013526","journal-title":"Clin Pract Cases Emerg Med"},{"key":"1334_CR67","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S1474-4422(20)30413-0","volume":"19","author":"S Muppidi","year":"2020","unstructured":"Muppidi S, Guptill JT, Jacob S, Li Y, Farrugia ME, Guidon AC, Tavee JO, Kaminski H, Howard JF, Cutter G, Wiendl H, Maas MB, Illa I, Mantegazza R, Murai H, Utsugisawa K, Nowak RJ, CARE-MG Study Group (2020) COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol 19:970\u2013971","journal-title":"Lancet Neurol"},{"key":"1334_CR68","doi-asserted-by":"crossref","unstructured":"Muralidhar Reddy Y, B SK, Osman S, Murthy JMK (2021) Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental? BMJ Case Rep 14","DOI":"10.1136\/bcr-2021-244146"},{"key":"1334_CR69","doi-asserted-by":"crossref","unstructured":"Nair AV, Ponraj L, Sivadasan A, Aaron S (2025) When HIV meets MG: is immune reconstitution in the mix? Neuroimmunol Rep 5:100263","DOI":"10.1016\/j.nerep.2025.100263"},{"key":"1334_CR70","unstructured":"Nata Pratama, Hardjo Lugito, Margaret, Andree Kurniawan, and Merlyn Tjiang (2014) Worsening muscle weakness in myasthenia gravis patient suffering dengue infection. J Trop Disease 2"},{"key":"1334_CR71","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/978-1-4419-8216-2_7","volume":"711","author":"HH Niller","year":"2011","unstructured":"Niller HH, Wolf H, Ay E, Minarovits J (2011) Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease. Adv Exp Med Biol 711:82\u2013102","journal-title":"Adv Exp Med Biol"},{"key":"1334_CR72","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1093\/infdis\/jiae600","volume":"231","author":"K Nowlan","year":"2025","unstructured":"Nowlan K, Hannolainen L, Assimakopoulou IM, D\u00fcrnsteiner P, Sarkkinen J, Suokas S, Hedman L, Tienari PJ, Hedman K, Niku M, Aaltonen LM, Huuskonen A, R\u00e4s\u00e4nen JV, Ilonen IK, M\u00e4yr\u00e4np\u00e4\u00e4 MI, Dunkel J, Laakso SM, S\u00f6derlund-Venermo M, Perdomo MF, Kek\u00e4l\u00e4inen E (2025) Parvovirus B19 and Human Herpes Virus 6B and 7 Are Frequently Found DNA Viruses in the Human Thymus But Show No Definitive Link With Myasthenia Gravis. J Infect Dis 231:e601\u2013e06","journal-title":"J Infect Dis"},{"key":"1334_CR73","doi-asserted-by":"crossref","unstructured":"Qiu D, Xia Z, Jiao X, Deng J, Zhang L, Li J (2018) Altered Gut Microbiota in Myasthenia Gravis. Front Microbiol 9:2627","DOI":"10.3389\/fmicb.2018.02627"},{"key":"1334_CR74","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00415-015-7639-1","volume":"262","author":"K Ragunathan","year":"2015","unstructured":"Ragunathan K, Pathak B, Dahal K (2015) MuSK myasthenia gravis as a manifestation of immune restoration disease in an HIV-positive patient. J Neurol 262:777\u2013778","journal-title":"J Neurol"},{"key":"1334_CR75","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3233\/JND-200520","volume":"7","author":"SB Ramaswamy","year":"2020","unstructured":"Ramaswamy SB, Govindarajan R (2020) COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome. J Neuromuscul Dis 7:361\u2013364","journal-title":"J Neuromuscul Dis"},{"key":"1334_CR76","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/JTO.0000000000000390","volume":"10","author":"D Rennspiess","year":"2015","unstructured":"Rennspiess D, Pujari S, Keijzers M, Abdul-Hamid MA, Hochstenbag M, Dingemans AM, Kurz AK, Speel EJ, Haugg A, Pastrana DV, Buck CB, De Baets MH, Zur Hausen A (2015) Detection of human polyomavirus 7 in human thymic epithelial tumors. J Thorac Oncol 10:360\u2013366","journal-title":"J Thorac Oncol"},{"key":"1334_CR77","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.7326\/L20-0845","volume":"173","author":"DA Restivo","year":"2020","unstructured":"Restivo DA, Centonze D, Alesina A, Marchese-Ragona R (2020) Myasthenia Gravis Associated With SARS-CoV-2 Infection. Ann Intern Med 173:1027\u20131028","journal-title":"Ann Intern Med"},{"key":"1334_CR78","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12016-016-8549-4","volume":"52","author":"M Robinet","year":"2017","unstructured":"Robinet M, Maillard S, Cron MA, Berrih-Aknin S, Le Panse R (2017) Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models. Clin Rev Allergy Immunol 52:133\u2013147","journal-title":"Clin Rev Allergy Immunol"},{"key":"1334_CR79","doi-asserted-by":"crossref","unstructured":"Robinson WH, Younis S, Love ZZ, Steinman L and T. V. Lanz (2024) Epstein-Barr virus as a potentiator of autoimmune diseases. Nat Rev Rheumatol 20:729\u2013740","DOI":"10.1038\/s41584-024-01167-9"},{"key":"1334_CR80","first-page":"e177","volume":"48","author":"A Saha","year":"2007","unstructured":"Saha A, Batra P, Vilhekar KY, Chaturvedi P (2007) Post-varicella myasthenia gravis. Singap Med J 48:e177\u2013e180","journal-title":"Singap Med J"},{"key":"1334_CR81","doi-asserted-by":"crossref","unstructured":"Saied Z, Rachdi A, Thamlaoui S, Nabli F, Jeridi C, Baffoun N, Kaddour C, Belal S and Ben Sassi S (2021) Myasthenia gravis and COVID-19: A case series and comparison with literature. Acta Neurol Scand 144:334\u201340","DOI":"10.1111\/ane.13440"},{"key":"1334_CR82","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1371\/journal.ppat.0020062","volume":"2","author":"W Savino","year":"2006","unstructured":"Savino W (2006) The thymus is a common target organ in infectious diseases. PLoS Pathog 2:e62","journal-title":"PLoS Pathog"},{"key":"1334_CR83","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3988\/jcn.2017.13.4.325","volume":"13","author":"HY Seok","year":"2017","unstructured":"Seok HY, Shin HY, Kim JK, Kim BJ, Oh J, Suh BC, Kim SY, Kang SY, Ahn SW, Bae JS (2017) The Impacts of Influenza Infection and Vaccination on Exacerbation of Myasthenia Gravis. J Clin Neurol 13:325\u2013330","journal-title":"J Clin Neurol"},{"key":"1334_CR84","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/bs.irn.2025.04.007","volume":"180","author":"AK Singh","year":"2025","unstructured":"Singh AK, Sudhan YG, Ramakrishna R, Durairajan SSK (2025) Viral agents in neuromuscular pathology. Int Rev Neurobiol 180:397\u2013434","journal-title":"Int Rev Neurobiol"},{"key":"1334_CR85","doi-asserted-by":"publisher","first-page":"106045","DOI":"10.1016\/j.clineuro.2020.106045","volume":"196","author":"S Singh","year":"2020","unstructured":"Singh S, Govindarajan R (2020) COVID-19 and generalized Myasthenia Gravis exacerbation: A case report. Clin Neurol Neurosurg 196:106045","journal-title":"Clin Neurol Neurosurg"},{"key":"1334_CR86","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1007\/s00415-020-10263-1","volume":"268","author":"S Sriwastava","year":"2021","unstructured":"Sriwastava S, Tandon M, Kataria S, Daimee M, Sultan S (2021) New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review. J Neurol 268:2690\u20132696","journal-title":"J Neurol"},{"key":"1334_CR87","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00415-022-11472-6","volume":"270","author":"Y Tereshko","year":"2023","unstructured":"Tereshko Y, Gigli GL, Pez S, De Pellegrin A, Valente M (2023) New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review. J Neurol 270:601\u2013609","journal-title":"J Neurol"},{"key":"1334_CR88","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mus.27919","volume":"68","author":"EV Thomas","year":"2023","unstructured":"Thomas EV, Bou G, Barton S, Hutto S, Garcia-Santibanez R (2023) COVID-19 infection in myasthenia gravis: Clinical course and outcomes. Muscle Nerve 68:171\u2013175","journal-title":"Muscle Nerve"},{"key":"1334_CR89","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1212\/WNL.28.3.273","volume":"28","author":"RS Tindall","year":"1978","unstructured":"Tindall RS, Cloud R, Luby J, Rosenberg RN (1978) Serum antibodies to cytomegalovirus in myasthenia gravis: effects of thymectomy and steroids. Neurology 28:273\u2013277","journal-title":"Neurology"},{"key":"1334_CR90","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","volume":"12","author":"E T\u00fcz\u00fcn","year":"2013","unstructured":"T\u00fcz\u00fcn E, Christadoss P (2013) Complement associated pathogenic mechanisms in myasthenia gravis. Autoimmun Rev 12:904\u2013911","journal-title":"Autoimmun Rev"},{"key":"1334_CR91","doi-asserted-by":"crossref","unstructured":"Uru\u00e7u, Lorena M, Andr\u00e9 G, de Albuquerque C, Naurath, Marcia N, Carreira MM, Garrido VE, Emmel BE, Gama R, Binato R, Hassan, Ianick SM (2022) Chikungunya virus infection in a patient with myasthenia gravis: a case report of lethal meningoencephalitis associated with high viral load. Neuroimmunol Rep 2","DOI":"10.1016\/j.nerep.2022.100099"},{"key":"1334_CR92","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jns.2014.08.044","volume":"346","author":"R Verma","year":"2014","unstructured":"Verma R, Sahu R, Holla V (2014) Neurological manifestations of dengue infection: a review. J Neurol Sci 346:26\u201334","journal-title":"J Neurol Sci"},{"key":"1334_CR93","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.clicom.2021.09.001","volume":"1","author":"H Victoria Probst, Nicole","year":"2021","unstructured":"Victoria Probst, Nicole H, Trier GH (2021) Antibodies to cytomegalovirus are elevated in myasthenia gravis. Clin Immunol Commun 1:4\u201312","journal-title":"Clin Immunol Commun"},{"key":"1334_CR94","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jhep.2018.01.040","volume":"68","author":"L Wang","year":"2018","unstructured":"Wang L, Gao F, Lin G, Yuan Y, Huang Y, Hao H, Zhuang H (2018) Association of hepatitis E virus infection and myasthenia gravis: A pilot study. J Hepatol 68:1318\u20131320","journal-title":"J Hepatol"},{"key":"1334_CR95","doi-asserted-by":"crossref","unstructured":"Wang YZ, Yan M, Tian FF, Zhang JM, Liu Q, Yang H, Zhou WB, Li J (2013) Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis. Inflammation 36:121\u201330","DOI":"10.1007\/s10753-012-9526-6"},{"key":"1334_CR96","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(18)30392-2","volume":"18","author":"GI Wolfe","year":"2019","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Str\u00f6bel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJGM, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Silvestri NJ, Conwit R, Sonett JR, Jaretzki A, Newsom-Davis J, Cutter GR, MGTX Study Group (2019) Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Lancet Neurol 18:259\u2013268","journal-title":"Lancet Neurol"},{"key":"1334_CR97","doi-asserted-by":"publisher","first-page":"1439899","DOI":"10.3389\/fneur.2024.1439899","volume":"15","author":"X Yang","year":"2024","unstructured":"Yang X, Zhang W, Guo J, Ma C, Li B (2024) Efficacy and safety of low-dose rituximab in the treatment of myasthenia gravis: a systemic review and meta-analysis. Front Neurol 15:1439899","journal-title":"Front Neurol"},{"key":"1334_CR98","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13027-023-00497-9","volume":"18","author":"L Zhao","year":"2023","unstructured":"Zhao L, Ding JY, Tao YL, Zhu K, Chen G (2023) Detection of Epstein-Barr virus infection in thymic epithelial tumors by nested PCR and Epstein-Barr-encoded RNA ISH. Infect Agent Cancer 18:37","journal-title":"Infect Agent Cancer"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-026-01334-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-026-01334-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-026-01334-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:02:17Z","timestamp":1791298937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-026-01334-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1334"],"URL":"https:\/\/doi.org\/10.1007\/s13365-026-01334-6","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"1 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"34"}}